Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Store and dispense Wegovy tablets in the original bottle
Clinical trials and real-world data consistently show significant weight loss from treatment with Ozempic, Semaglutide and Tirzepatide: Unfortunately, weight regain is a well-documented phenomenon after discontinuation of treatment: SURMOUNT 4 trial- Weight regain after stopping Tirzepatide after 36 weeks versus continuation of treatment Beyond weight regain, the discontinuation of GLP-1 agonists may reverse cardiometabolic benefits: Ongoing trials (e.g., SELECT and SURPASS-CVOT) aim to clarify whether continued use is necessary for sustained cardiovascular risk reduction
However, its important to remember that Semaglutide is not a cancer prevention drug
Improves Sleep & Cellular Repair: Encourages deeper restorative sleep cycles for tissue and collagen regeneration
US$ 27.48
US$ 21.93
US$ 27.75
